Abingdon Health Plc engages in the development, manufacturing, and distribution of diagnostic devices and provide consultancy services to businesses in the diagnostics sector. Its products include home self-test, COVID-19 self test, nucleic acid detection, and plant health test. The company was founded by Brett David Pollard, Chris Henry Francis Yates, and Christopher William Hand on January 16, 2008 and is headquartered in York, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company